Health Economics and Payer Evidence, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, SwedenGothenburg, Vastra Gotaland, Sweden
I do not have any relevant financial / non-financial relationships with any proprietary interests.
1096 - Fully Vaccinated Individuals with Immunocompromised Conditions (IC) are Still at Increased Risk of Severe COVID-19 Outcomes From the Omicron Variant: Initial Results From INFORM, a Retrospective Health Database Observational Study in England
Friday, October 13, 202310:45 AM – 11:00 AM US ET
1095 - Increased Risk of COVID-19 Hospitalization and Death in Vaccinated Patients with End-Stage Renal Disease (ESRD) and Dialysis: Initial Results from INFORM, a Retrospective Health Database Observational Study in England
Friday, October 13, 202311:00 AM – 11:15 AM US ET
